

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 7.17347470 |
| 2 | cytidine metabolic process (GO:0046087) | 6.65462643 |
| 3 | cytidine catabolic process (GO:0006216) | 6.65462643 |
| 4 | cytidine deamination (GO:0009972) | 6.65462643 |
| 5 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.39205819 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.72913245 |
| 7 | signal peptide processing (GO:0006465) | 4.92162588 |
| 8 | proteasome assembly (GO:0043248) | 3.95422879 |
| 9 | negative regulation by host of viral transcription (GO:0043922) | 3.90022091 |
| 10 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.84686230 |
| 11 | cullin deneddylation (GO:0010388) | 3.80772144 |
| 12 | protein deneddylation (GO:0000338) | 3.79391411 |
| 13 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.78192577 |
| 14 | regulation of chronic inflammatory response (GO:0002676) | 3.74568588 |
| 15 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.71324242 |
| 16 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.64148856 |
| 17 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.63604846 |
| 18 | protein-cofactor linkage (GO:0018065) | 3.61766193 |
| 19 | protein K11-linked deubiquitination (GO:0035871) | 3.55986277 |
| 20 | actin nucleation (GO:0045010) | 3.54764850 |
| 21 | activated T cell proliferation (GO:0050798) | 3.54675043 |
| 22 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.45940717 |
| 23 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.45184118 |
| 24 | protein neddylation (GO:0045116) | 3.44548409 |
| 25 | cellular response to interleukin-15 (GO:0071350) | 3.39692088 |
| 26 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.37261488 |
| 27 | negative T cell selection (GO:0043383) | 3.33813346 |
| 28 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.31504836 |
| 29 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.31504836 |
| 30 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.30612114 |
| 31 | iron-sulfur cluster assembly (GO:0016226) | 3.30487830 |
| 32 | metallo-sulfur cluster assembly (GO:0031163) | 3.30487830 |
| 33 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.28753949 |
| 34 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.28753949 |
| 35 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.28753949 |
| 36 | protein complex biogenesis (GO:0070271) | 3.28467001 |
| 37 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.28095726 |
| 38 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.24354601 |
| 39 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.24153117 |
| 40 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.23564894 |
| 41 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.17652820 |
| 42 | ATP synthesis coupled proton transport (GO:0015986) | 3.17652820 |
| 43 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.17102102 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.16413397 |
| 45 | respiratory chain complex IV assembly (GO:0008535) | 3.14856612 |
| 46 | regulation of regulatory T cell differentiation (GO:0045589) | 3.14434200 |
| 47 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.12600051 |
| 48 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.12027754 |
| 49 | respiratory electron transport chain (GO:0022904) | 3.11971435 |
| 50 | electron transport chain (GO:0022900) | 3.11588245 |
| 51 | eosinophil chemotaxis (GO:0048245) | 3.10567591 |
| 52 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.08523293 |
| 53 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.08523293 |
| 54 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.05815260 |
| 55 | positive regulation of defense response to virus by host (GO:0002230) | 3.04703746 |
| 56 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.04446993 |
| 57 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.03943925 |
| 58 | cytolysis (GO:0019835) | 3.01971958 |
| 59 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.94210305 |
| 60 | cytochrome complex assembly (GO:0017004) | 2.94113143 |
| 61 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.93446038 |
| 62 | positive regulation of tolerance induction (GO:0002645) | 2.92662734 |
| 63 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.88496484 |
| 64 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.88496484 |
| 65 | sequestering of actin monomers (GO:0042989) | 2.87631486 |
| 66 | interferon-gamma production (GO:0032609) | 2.87587810 |
| 67 | rRNA modification (GO:0000154) | 2.87259488 |
| 68 | adaptation of signaling pathway (GO:0023058) | 2.86484472 |
| 69 | positive regulation of cell killing (GO:0031343) | 2.86257969 |
| 70 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.85710023 |
| 71 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.85168074 |
| 72 | serotonin receptor signaling pathway (GO:0007210) | 2.84987340 |
| 73 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.84797001 |
| 74 | negative regulation of ligase activity (GO:0051352) | 2.84797001 |
| 75 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.84646305 |
| 76 | negative regulation of T cell apoptotic process (GO:0070233) | 2.84099230 |
| 77 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.84071528 |
| 78 | eosinophil migration (GO:0072677) | 2.82505181 |
| 79 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.82290430 |
| 80 | tryptophan catabolic process (GO:0006569) | 2.81434653 |
| 81 | indole-containing compound catabolic process (GO:0042436) | 2.81434653 |
| 82 | indolalkylamine catabolic process (GO:0046218) | 2.81434653 |
| 83 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.79495679 |
| 84 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.78467622 |
| 85 | positive T cell selection (GO:0043368) | 2.77883209 |
| 86 | platelet dense granule organization (GO:0060155) | 2.76877209 |
| 87 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.76449513 |
| 88 | DNA double-strand break processing (GO:0000729) | 2.75818658 |
| 89 | regulation of T cell tolerance induction (GO:0002664) | 2.75312717 |
| 90 | sulfation (GO:0051923) | 2.74237994 |
| 91 | rRNA methylation (GO:0031167) | 2.73944481 |
| 92 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.72492637 |
| 93 | T cell migration (GO:0072678) | 2.71317717 |
| 94 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.70927630 |
| 95 | regulation of cellular amine metabolic process (GO:0033238) | 2.69548139 |
| 96 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.69326555 |
| 97 | neuron fate determination (GO:0048664) | 2.68842952 |
| 98 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.66623638 |
| 99 | NADH dehydrogenase complex assembly (GO:0010257) | 2.66623638 |
| 100 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.66623638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.67120963 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.29912327 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.19474594 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.90559740 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.83718625 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.82653440 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.71327864 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.69652269 |
| 9 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.69105091 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.66088140 |
| 11 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.39785834 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.37688465 |
| 13 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.28791658 |
| 14 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.23264344 |
| 15 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.19723470 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.17871314 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.15249166 |
| 18 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.12790065 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.06604688 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.87040723 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.84260694 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.73927334 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.73505689 |
| 24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.72325274 |
| 25 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.70285534 |
| 26 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.68541407 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.68170667 |
| 28 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.65238973 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.64356552 |
| 30 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.63544972 |
| 31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.61048675 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.58715058 |
| 33 | EWS_26573619_Chip-Seq_HEK293_Human | 1.56790512 |
| 34 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.55997758 |
| 35 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.54370830 |
| 36 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53247113 |
| 37 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.52747540 |
| 38 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.52341534 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.52336725 |
| 40 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.50085302 |
| 41 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.50085302 |
| 42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48910238 |
| 43 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.46001419 |
| 44 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.42470733 |
| 45 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.40871302 |
| 46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.40562893 |
| 47 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.39171897 |
| 48 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.39003006 |
| 49 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.38469774 |
| 50 | P300_19829295_ChIP-Seq_ESCs_Human | 1.38240086 |
| 51 | FUS_26573619_Chip-Seq_HEK293_Human | 1.34989722 |
| 52 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.34104967 |
| 53 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.33056918 |
| 54 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.31853305 |
| 55 | MYB_26560356_Chip-Seq_TH2_Human | 1.30978068 |
| 56 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.30714406 |
| 57 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.29061207 |
| 58 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.26214103 |
| 59 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.25739354 |
| 60 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25194837 |
| 61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24132277 |
| 62 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.21358870 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20398779 |
| 64 | NCOR_22424771_ChIP-Seq_293T_Human | 1.18794430 |
| 65 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.17033900 |
| 66 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.17033900 |
| 67 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.16924590 |
| 68 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.16339455 |
| 69 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16065125 |
| 70 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.15219230 |
| 71 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.14910345 |
| 72 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.12001168 |
| 73 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.11646078 |
| 74 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11517685 |
| 75 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.11072365 |
| 76 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10964209 |
| 77 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.10578623 |
| 78 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.09453178 |
| 79 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.08462253 |
| 80 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.07586526 |
| 81 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.07518705 |
| 82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06786125 |
| 83 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05696401 |
| 84 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.05377661 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04802670 |
| 86 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.03093550 |
| 87 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.01318115 |
| 88 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.01318115 |
| 89 | AR_20517297_ChIP-Seq_VCAP_Human | 1.01232835 |
| 90 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.00732809 |
| 91 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.00347409 |
| 92 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99737290 |
| 93 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.97187404 |
| 94 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96700846 |
| 95 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.95999687 |
| 96 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.95706509 |
| 97 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.95467580 |
| 98 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.94658878 |
| 99 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.94026720 |
| 100 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.93519852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.51698891 |
| 2 | MP0002102_abnormal_ear_morphology | 3.14268448 |
| 3 | MP0009785_altered_susceptibility_to | 2.55485288 |
| 4 | MP0010386_abnormal_urinary_bladder | 2.37016170 |
| 5 | MP0001873_stomach_inflammation | 2.25459126 |
| 6 | MP0003763_abnormal_thymus_physiology | 2.18586708 |
| 7 | MP0001968_abnormal_touch/_nociception | 2.14074863 |
| 8 | MP0009333_abnormal_splenocyte_physiolog | 2.12140061 |
| 9 | MP0005551_abnormal_eye_electrophysiolog | 2.08967384 |
| 10 | MP0003195_calcinosis | 2.07280999 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.06902841 |
| 12 | MP0002277_abnormal_respiratory_mucosa | 2.05810251 |
| 13 | MP0005387_immune_system_phenotype | 1.97878190 |
| 14 | MP0001790_abnormal_immune_system | 1.97878190 |
| 15 | MP0005645_abnormal_hypothalamus_physiol | 1.97335030 |
| 16 | MP0001835_abnormal_antigen_presentation | 1.87012762 |
| 17 | MP0005310_abnormal_salivary_gland | 1.86988835 |
| 18 | MP0008872_abnormal_physiological_respon | 1.82646175 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.82173006 |
| 20 | MP0006072_abnormal_retinal_apoptosis | 1.80765417 |
| 21 | MP0001501_abnormal_sleep_pattern | 1.79237690 |
| 22 | MP0002876_abnormal_thyroid_physiology | 1.72379469 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 1.70238854 |
| 24 | MP0001905_abnormal_dopamine_level | 1.68665358 |
| 25 | MP0004147_increased_porphyrin_level | 1.60523071 |
| 26 | MP0006082_CNS_inflammation | 1.60475710 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.59774859 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.59549051 |
| 29 | MP0003866_abnormal_defecation | 1.57008248 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.54801963 |
| 31 | MP0005377_hearing/vestibular/ear_phenot | 1.54036557 |
| 32 | MP0003878_abnormal_ear_physiology | 1.54036557 |
| 33 | MP0002006_tumorigenesis | 1.50214639 |
| 34 | MP0001800_abnormal_humoral_immune | 1.47715005 |
| 35 | MP0002837_dystrophic_cardiac_calcinosis | 1.41872172 |
| 36 | MP0005084_abnormal_gallbladder_morpholo | 1.40072816 |
| 37 | MP0002736_abnormal_nociception_after | 1.39407532 |
| 38 | MP0002420_abnormal_adaptive_immunity | 1.39373699 |
| 39 | MP0001485_abnormal_pinna_reflex | 1.37742878 |
| 40 | MP0005085_abnormal_gallbladder_physiolo | 1.37625619 |
| 41 | MP0001984_abnormal_olfaction | 1.37310039 |
| 42 | MP0003786_premature_aging | 1.36945863 |
| 43 | MP0001819_abnormal_immune_cell | 1.34244770 |
| 44 | MP0000685_abnormal_immune_system | 1.34125454 |
| 45 | MP0002723_abnormal_immune_serum | 1.32394892 |
| 46 | MP0003252_abnormal_bile_duct | 1.29159934 |
| 47 | MP0005025_abnormal_response_to | 1.27914588 |
| 48 | MP0009745_abnormal_behavioral_response | 1.24746218 |
| 49 | MP0005253_abnormal_eye_physiology | 1.24573760 |
| 50 | MP0000372_irregular_coat_pigmentation | 1.24171313 |
| 51 | MP0002693_abnormal_pancreas_physiology | 1.23323807 |
| 52 | MP0002272_abnormal_nervous_system | 1.22310732 |
| 53 | MP0003880_abnormal_central_pattern | 1.21930448 |
| 54 | MP0008877_abnormal_DNA_methylation | 1.19578119 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.18756143 |
| 56 | MP0008058_abnormal_DNA_repair | 1.13159921 |
| 57 | MP0006276_abnormal_autonomic_nervous | 1.12795472 |
| 58 | MP0001764_abnormal_homeostasis | 1.11744917 |
| 59 | MP0005389_reproductive_system_phenotype | 1.11402716 |
| 60 | MP0001919_abnormal_reproductive_system | 1.10609521 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.08932728 |
| 62 | MP0000716_abnormal_immune_system | 1.08137069 |
| 63 | MP0001348_abnormal_lacrimal_gland | 1.05505972 |
| 64 | MP0002452_abnormal_antigen_presenting | 1.04867247 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 1.02867091 |
| 66 | MP0005360_urolithiasis | 1.02624085 |
| 67 | MP0004742_abnormal_vestibular_system | 1.02521575 |
| 68 | MP0001529_abnormal_vocalization | 1.00876504 |
| 69 | MP0001188_hyperpigmentation | 1.00354008 |
| 70 | MP0002933_joint_inflammation | 0.98464084 |
| 71 | MP0000703_abnormal_thymus_morphology | 0.98016474 |
| 72 | MP0002398_abnormal_bone_marrow | 0.96413450 |
| 73 | MP0003724_increased_susceptibility_to | 0.94958579 |
| 74 | MP0002405_respiratory_system_inflammati | 0.94154693 |
| 75 | MP0001845_abnormal_inflammatory_respons | 0.93281649 |
| 76 | MP0005075_abnormal_melanosome_morpholog | 0.92082076 |
| 77 | MP0000538_abnormal_urinary_bladder | 0.92057633 |
| 78 | MP0003137_abnormal_impulse_conducting | 0.89747806 |
| 79 | MP0001970_abnormal_pain_threshold | 0.89535364 |
| 80 | MP0001486_abnormal_startle_reflex | 0.88740663 |
| 81 | MP0005410_abnormal_fertilization | 0.87644364 |
| 82 | MP0002722_abnormal_immune_system | 0.87538901 |
| 83 | MP0002733_abnormal_thermal_nociception | 0.87122367 |
| 84 | MP0004924_abnormal_behavior | 0.86108512 |
| 85 | MP0005386_behavior/neurological_phenoty | 0.86108512 |
| 86 | MP0002160_abnormal_reproductive_system | 0.85654725 |
| 87 | MP0003183_abnormal_peptide_metabolism | 0.84474056 |
| 88 | MP0005646_abnormal_pituitary_gland | 0.81881579 |
| 89 | MP0000689_abnormal_spleen_morphology | 0.81429248 |
| 90 | MP0008057_abnormal_DNA_replication | 0.81418550 |
| 91 | MP0008007_abnormal_cellular_replicative | 0.80480067 |
| 92 | MP0003045_fibrosis | 0.80215329 |
| 93 | MP0005636_abnormal_mineral_homeostasis | 0.79136520 |
| 94 | MP0004043_abnormal_pH_regulation | 0.78415398 |
| 95 | MP0002735_abnormal_chemical_nociception | 0.77757406 |
| 96 | MP0005379_endocrine/exocrine_gland_phen | 0.77518089 |
| 97 | MP0004145_abnormal_muscle_electrophysio | 0.77256011 |
| 98 | MP0002429_abnormal_blood_cell | 0.76888890 |
| 99 | MP0002928_abnormal_bile_duct | 0.76648316 |
| 100 | MP0002064_seizures | 0.76444812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 3.89537042 |
| 2 | Mitochondrial inheritance (HP:0001427) | 3.82467600 |
| 3 | Congenital stationary night blindness (HP:0007642) | 3.74250903 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.65062708 |
| 5 | IgG deficiency (HP:0004315) | 3.64353956 |
| 6 | T lymphocytopenia (HP:0005403) | 3.55722357 |
| 7 | Hepatocellular necrosis (HP:0001404) | 3.53231301 |
| 8 | Aplastic anemia (HP:0001915) | 3.49105434 |
| 9 | Acute encephalopathy (HP:0006846) | 3.47173529 |
| 10 | Increased CSF lactate (HP:0002490) | 3.44472085 |
| 11 | Abnormality of T cell number (HP:0011839) | 3.44155171 |
| 12 | Severe combined immunodeficiency (HP:0004430) | 3.27474352 |
| 13 | Stomatitis (HP:0010280) | 3.27091254 |
| 14 | Volvulus (HP:0002580) | 3.26667871 |
| 15 | Progressive macrocephaly (HP:0004481) | 3.26532795 |
| 16 | Hepatic necrosis (HP:0002605) | 3.17785878 |
| 17 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.15232763 |
| 18 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.15232763 |
| 19 | Autoimmune hemolytic anemia (HP:0001890) | 3.01207047 |
| 20 | Hypoproteinemia (HP:0003075) | 3.00488977 |
| 21 | 3-Methylglutaconic aciduria (HP:0003535) | 2.93186116 |
| 22 | Thyroiditis (HP:0100646) | 2.92156998 |
| 23 | Pancreatic cysts (HP:0001737) | 2.91420547 |
| 24 | Urethral obstruction (HP:0000796) | 2.80348880 |
| 25 | Cerebral edema (HP:0002181) | 2.79601058 |
| 26 | Hypothermia (HP:0002045) | 2.77811686 |
| 27 | Optic disc pallor (HP:0000543) | 2.69173977 |
| 28 | Renal cortical cysts (HP:0000803) | 2.68427279 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.67034254 |
| 30 | Abnormality of T cells (HP:0002843) | 2.66382833 |
| 31 | Abnormality of B cell number (HP:0010975) | 2.64438089 |
| 32 | Abolished electroretinogram (ERG) (HP:0000550) | 2.63282387 |
| 33 | Attenuation of retinal blood vessels (HP:0007843) | 2.59374707 |
| 34 | Increased hepatocellular lipid droplets (HP:0006565) | 2.59326070 |
| 35 | Renal Fanconi syndrome (HP:0001994) | 2.59039404 |
| 36 | Lipid accumulation in hepatocytes (HP:0006561) | 2.58197595 |
| 37 | Chronic bronchitis (HP:0004469) | 2.57268801 |
| 38 | Increased IgM level (HP:0003496) | 2.56310746 |
| 39 | B lymphocytopenia (HP:0010976) | 2.49138788 |
| 40 | Autoimmune thrombocytopenia (HP:0001973) | 2.48290834 |
| 41 | Constricted visual fields (HP:0001133) | 2.48075746 |
| 42 | Combined immunodeficiency (HP:0005387) | 2.44306504 |
| 43 | Generalized aminoaciduria (HP:0002909) | 2.43133231 |
| 44 | Abnormality of the prostate (HP:0008775) | 2.39724490 |
| 45 | Increased intramyocellular lipid droplets (HP:0012240) | 2.37098412 |
| 46 | True hermaphroditism (HP:0010459) | 2.35572174 |
| 47 | Pancytopenia (HP:0001876) | 2.33846722 |
| 48 | Increased serum lactate (HP:0002151) | 2.32800771 |
| 49 | Lactic acidosis (HP:0003128) | 2.30270348 |
| 50 | Methylmalonic acidemia (HP:0002912) | 2.29673887 |
| 51 | Abnormality of eosinophils (HP:0001879) | 2.27691080 |
| 52 | Congenital, generalized hypertrichosis (HP:0004540) | 2.23646206 |
| 53 | Chronic diarrhea (HP:0002028) | 2.22701681 |
| 54 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.19734720 |
| 55 | Methylmalonic aciduria (HP:0012120) | 2.19105790 |
| 56 | Encephalitis (HP:0002383) | 2.18303296 |
| 57 | Congenital sensorineural hearing impairment (HP:0008527) | 2.18061127 |
| 58 | Keratoconjunctivitis (HP:0001096) | 2.14242276 |
| 59 | Optic neuritis (HP:0100653) | 2.13771702 |
| 60 | Retrobulbar optic neuritis (HP:0100654) | 2.13771702 |
| 61 | Respiratory failure (HP:0002878) | 2.12620087 |
| 62 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.09652925 |
| 63 | Lymphopenia (HP:0001888) | 2.08671403 |
| 64 | Lethargy (HP:0001254) | 2.08531909 |
| 65 | Decreased circulating renin level (HP:0003351) | 2.07727956 |
| 66 | Pancreatic fibrosis (HP:0100732) | 2.07235589 |
| 67 | Abnormal albumin level (HP:0012116) | 2.02919398 |
| 68 | Hypoalbuminemia (HP:0003073) | 2.02919398 |
| 69 | Abnormality of midbrain morphology (HP:0002418) | 2.02125837 |
| 70 | Molar tooth sign on MRI (HP:0002419) | 2.02125837 |
| 71 | Increased muscle lipid content (HP:0009058) | 2.01866079 |
| 72 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.00023601 |
| 73 | Short tibia (HP:0005736) | 1.99580601 |
| 74 | Bronchitis (HP:0012387) | 1.97172999 |
| 75 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.95233656 |
| 76 | Pendular nystagmus (HP:0012043) | 1.93366591 |
| 77 | Neuroendocrine neoplasm (HP:0100634) | 1.92977456 |
| 78 | IgM deficiency (HP:0002850) | 1.92218900 |
| 79 | Decreased central vision (HP:0007663) | 1.92030705 |
| 80 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.90832758 |
| 81 | Pheochromocytoma (HP:0002666) | 1.90536398 |
| 82 | Asplenia (HP:0001746) | 1.87781316 |
| 83 | Glycosuria (HP:0003076) | 1.87622029 |
| 84 | Abnormality of urine glucose concentration (HP:0011016) | 1.87622029 |
| 85 | Abnormality of the renal cortex (HP:0011035) | 1.87343578 |
| 86 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.85757770 |
| 87 | Type 2 muscle fiber atrophy (HP:0003554) | 1.81725823 |
| 88 | Hyperglycinemia (HP:0002154) | 1.81656520 |
| 89 | Type I transferrin isoform profile (HP:0003642) | 1.76597705 |
| 90 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.74584061 |
| 91 | Large for gestational age (HP:0001520) | 1.73587552 |
| 92 | Leukodystrophy (HP:0002415) | 1.73207834 |
| 93 | Hyperglycinuria (HP:0003108) | 1.71576128 |
| 94 | Keratoconjunctivitis sicca (HP:0001097) | 1.70040295 |
| 95 | Eosinophilia (HP:0001880) | 1.69447579 |
| 96 | Abnormality of T cell physiology (HP:0011840) | 1.68427161 |
| 97 | Opisthotonus (HP:0002179) | 1.66128191 |
| 98 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.65431628 |
| 99 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.65289294 |
| 100 | Nephronophthisis (HP:0000090) | 1.64698602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.17867241 |
| 2 | TSSK6 | 3.69411990 |
| 3 | ADRBK2 | 3.36093265 |
| 4 | FRK | 3.13653686 |
| 5 | KDR | 3.08626302 |
| 6 | MAP4K2 | 2.49055602 |
| 7 | VRK2 | 2.44146976 |
| 8 | TLK1 | 2.42226679 |
| 9 | TESK2 | 2.41842754 |
| 10 | MAP4K1 | 2.26829987 |
| 11 | MAP3K9 | 2.22462593 |
| 12 | TAF1 | 2.08279066 |
| 13 | BCKDK | 1.99655116 |
| 14 | TAOK3 | 1.94571320 |
| 15 | MST4 | 1.91749688 |
| 16 | BUB1 | 1.90008665 |
| 17 | NEK1 | 1.88253811 |
| 18 | VRK1 | 1.86641991 |
| 19 | ZAK | 1.86522227 |
| 20 | MAP3K12 | 1.82929250 |
| 21 | WNK3 | 1.76560976 |
| 22 | WNK4 | 1.67178494 |
| 23 | GRK1 | 1.59845957 |
| 24 | ITK | 1.47286303 |
| 25 | EIF2AK3 | 1.41740778 |
| 26 | CASK | 1.41232963 |
| 27 | LIMK1 | 1.41109747 |
| 28 | MARK1 | 1.38294588 |
| 29 | TRIM28 | 1.27625015 |
| 30 | STK39 | 1.26664615 |
| 31 | OXSR1 | 1.24844335 |
| 32 | SCYL2 | 1.22480330 |
| 33 | PINK1 | 1.21290356 |
| 34 | BCR | 1.11087206 |
| 35 | NUAK1 | 1.09535804 |
| 36 | TESK1 | 1.09404854 |
| 37 | PASK | 1.06670252 |
| 38 | ERBB3 | 0.97355453 |
| 39 | PIK3CG | 0.94036599 |
| 40 | TEC | 0.92221662 |
| 41 | CSNK1G3 | 0.89621147 |
| 42 | MUSK | 0.88644705 |
| 43 | CSNK1G2 | 0.87852960 |
| 44 | INSRR | 0.87818143 |
| 45 | BMPR1B | 0.87546655 |
| 46 | MAPK13 | 0.86641462 |
| 47 | ADRBK1 | 0.86200629 |
| 48 | IKBKB | 0.84539694 |
| 49 | TIE1 | 0.84054968 |
| 50 | PRKCQ | 0.82169326 |
| 51 | MAPKAPK3 | 0.79214514 |
| 52 | CSK | 0.75489457 |
| 53 | CSNK1G1 | 0.74323037 |
| 54 | DAPK1 | 0.72528876 |
| 55 | GRK6 | 0.72448213 |
| 56 | FES | 0.70426694 |
| 57 | MAPKAPK5 | 0.68488499 |
| 58 | PLK3 | 0.67046795 |
| 59 | IKBKE | 0.66753085 |
| 60 | MYLK | 0.66571940 |
| 61 | SYK | 0.63994676 |
| 62 | CSNK1A1L | 0.62150710 |
| 63 | LCK | 0.61082791 |
| 64 | CAMK2A | 0.60023321 |
| 65 | NME1 | 0.59666326 |
| 66 | PRKCE | 0.59022180 |
| 67 | SRPK1 | 0.54842593 |
| 68 | MAP2K6 | 0.53352528 |
| 69 | MATK | 0.52930087 |
| 70 | GRK5 | 0.50553464 |
| 71 | GRK7 | 0.50467171 |
| 72 | CSF1R | 0.48190935 |
| 73 | DYRK2 | 0.47047138 |
| 74 | IGF1R | 0.46983326 |
| 75 | STK16 | 0.45663832 |
| 76 | ACVR1B | 0.44832282 |
| 77 | EIF2AK2 | 0.42567830 |
| 78 | CSNK1A1 | 0.40332245 |
| 79 | BTK | 0.40285288 |
| 80 | LYN | 0.40096943 |
| 81 | MAP2K7 | 0.39517644 |
| 82 | RPS6KA5 | 0.39260695 |
| 83 | PRKCG | 0.39040325 |
| 84 | PRKCA | 0.38474031 |
| 85 | CLK1 | 0.37510513 |
| 86 | PBK | 0.36962516 |
| 87 | MKNK1 | 0.36840491 |
| 88 | PRKACA | 0.34317262 |
| 89 | OBSCN | 0.32717200 |
| 90 | MAPK15 | 0.32467914 |
| 91 | PLK2 | 0.31315923 |
| 92 | TBK1 | 0.30810052 |
| 93 | CSNK2A1 | 0.30642031 |
| 94 | CSNK2A2 | 0.30106358 |
| 95 | PIK3CA | 0.29706287 |
| 96 | PRKCB | 0.28590568 |
| 97 | STK38L | 0.28061490 |
| 98 | EIF2AK1 | 0.25864645 |
| 99 | ZAP70 | 0.23814557 |
| 100 | PRKCH | 0.23259747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.02937114 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.97016439 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.29787251 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.96487289 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.83106098 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.04689822 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.96946002 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 1.92738600 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.87577212 |
| 10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.84905772 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.83235290 |
| 12 | Huntingtons disease_Homo sapiens_hsa05016 | 1.80344919 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.78370002 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 1.71935357 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.70278615 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.65991177 |
| 17 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.62094068 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.58736237 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.54874898 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.51007756 |
| 21 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.47977968 |
| 22 | Basal transcription factors_Homo sapiens_hsa03022 | 1.47889816 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.47059174 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.44248068 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.35664156 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.35346321 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.34922777 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33215518 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.32109738 |
| 30 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.31812161 |
| 31 | Nicotine addiction_Homo sapiens_hsa05033 | 1.29480890 |
| 32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.28137654 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.25858945 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.23873378 |
| 35 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.21622047 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21179417 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.20881538 |
| 38 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.18735761 |
| 39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.15746235 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.15200719 |
| 41 | Taste transduction_Homo sapiens_hsa04742 | 1.06671442 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03261904 |
| 43 | RNA degradation_Homo sapiens_hsa03018 | 1.01827790 |
| 44 | Homologous recombination_Homo sapiens_hsa03440 | 0.98219041 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.96956000 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.96308190 |
| 47 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.92702120 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.92458812 |
| 49 | Ribosome_Homo sapiens_hsa03010 | 0.92227555 |
| 50 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.86311951 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.86078674 |
| 52 | RNA transport_Homo sapiens_hsa03013 | 0.85413208 |
| 53 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.82299946 |
| 54 | Spliceosome_Homo sapiens_hsa03040 | 0.80735016 |
| 55 | Asthma_Homo sapiens_hsa05310 | 0.79858339 |
| 56 | Measles_Homo sapiens_hsa05162 | 0.78430653 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77540561 |
| 58 | Purine metabolism_Homo sapiens_hsa00230 | 0.76525637 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76036737 |
| 60 | Peroxisome_Homo sapiens_hsa04146 | 0.72418928 |
| 61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.72084476 |
| 62 | Olfactory transduction_Homo sapiens_hsa04740 | 0.71304869 |
| 63 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.69197373 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.68689349 |
| 65 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68339458 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66555396 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.65156055 |
| 68 | Mismatch repair_Homo sapiens_hsa03430 | 0.64205841 |
| 69 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62629008 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62059612 |
| 71 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61092506 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58848002 |
| 73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.55250393 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55074220 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53385843 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.53103156 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52164632 |
| 78 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52090308 |
| 79 | Morphine addiction_Homo sapiens_hsa05032 | 0.51245478 |
| 80 | Legionellosis_Homo sapiens_hsa05134 | 0.50068536 |
| 81 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.49212159 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.47329384 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46723677 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45767196 |
| 85 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45688079 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45487871 |
| 87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43925254 |
| 88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42549284 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42278864 |
| 90 | DNA replication_Homo sapiens_hsa03030 | 0.41377371 |
| 91 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.40326438 |
| 92 | Salivary secretion_Homo sapiens_hsa04970 | 0.39811369 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.36341415 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33776271 |
| 95 | Mineral absorption_Homo sapiens_hsa04978 | 0.32747536 |
| 96 | GABAergic synapse_Homo sapiens_hsa04727 | 0.32292371 |
| 97 | Insulin secretion_Homo sapiens_hsa04911 | 0.32176212 |
| 98 | Base excision repair_Homo sapiens_hsa03410 | 0.32103777 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.30734282 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.29472886 |

